Patent Yard Sign in
Canadian application, no grantCanada

Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof

CA 2376078 A1 · Owner: Melvin, William Thomas · Inventors: Melvin, William Thomas; Stirk, Christina Maureen; Thompson, William Douglas

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Fibrin degradation products stimulate cell proliferation and angiogenesis. The present invention provides peptides, analogs and antibodies which are useful in the modulation of binding of fibrin fragment E to cell receptors and the modulation of such activity.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 7, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 7, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 7, 2000
GrantedNo grant recorded
Term endedJune 7, 2020
Patent numberCA 2376078 A1
Classification (IPC)C07K7/08 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJune 7, 2000Term endedJune 7, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.